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Abstract
Background: Low mean arterial pressure (MAP) can cause low renal blood flow and damage the kidneys. However,
in the general population, it remains unclear whether or not decline in renal function is related to MAP. The
present study examined the relationship between MAP and decreased glomerular filtration rate(GFR) in participans
aged ≥35 years from the Liaoning province of China.
Methods: A total of 11345 representative individuals aged ≥ 35 years was selected and a cross-sectional survey was
conducted from January 2012 to August 2013 to describe the gender-specific prevalence and factors associated
with decreased GFR in rural areas of Liaoning Province.
Results: Men with decreased eGFR (eGFR < 60ml/min per 1.73m2) were older, and had higher meanWC, systolic
and diastolic BP, PP, MAP, total fasting glucose, LDL-C ,glyceride and uric acid levels and were current drinker/
smoker at the baseline (all P < 0.05). Those with low education level, low income, low physical activity, low
hemoglobin and HDL-C level had decreased eGFR (all P < 0.05). In women, the results were similar to those of men,
but DBP and drinking status had no associations with the eGFR at the baseline (all P < 0.05). After adjustment for
age, men with MAP of >112.2 mmHg versus ≤ 93.8 mmHg had ORs for decreased eGFR of 2.367 (95 % CI: 1.248
to 4.488) .After multivariable adjustment, an MAP of >112.2 mmHg versus ≤93.8 mmHg had an OR for decreased
eGFR of 3.249 (95 % CI:1.394 to 7.575) in men, whereas in women, MAP was not associated with decreased eGFR.
Conclusions: MAP was associated with decreased eGFR in men, while in women MAP was not associated with
decreased eGFR. These findings provide some evidence that a different adaptive response to renal regulation may
exist in males and females.
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Background
Chronic kidney disease (CKD) is recognized as a global
public health problem ,and patients with CKD have a
significantly increased risk of cardiovascular disease [1].
Mild renal insufficiency has been considered to be an in-
dependent risk factor for cardiovascular disease, and the
correlation in people, in the absence of other cardiovas-
cular risk factors has been confirmed[2]. Mean arterial
pressure (MAP) is considered to be the perfusion
pressure for the organs of the body. Low MAP can cause
low renal blood flow (RBF) and damage the kidney [3].
However, this doesn’t mean that RBF increases as the
MAP increases [4–7].
Recent interest has been aroused in the relationship of
renal damage with arterial stiffness evaluated by the aug-
mentation index (AIx) and blood pressure including cen-
tral blood pressure (cBP) and peripheral blood pressure
(pBP). Several studies have investigated the association
of AIx, cBP and pBP with glomerular filtration rate (GFR),
but they have obtained inconsistent results [8–11]. How
MAP affects kidney function and gender differences in
this mechanism remains unclear.
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In the general population, is unknown how MAP
influences the GFR? This study examined the relation
between MAP and decreased GFR in participants aged ≥
35 years from the Liaoning province of China. Further,




The study was approved by the Ethics Committee of
China Medical University (Shenyang, China). Liaoning
Province is located in Northeast China. A representative
sample of people aged ≥35 years was selected, and a
cross-sectional survey was conducted from January 2012
to August 2013 to describe the sex-specific prevalence
and factors associated with decreased GFR in rural areas
of Liaoning Province. The study adopted a multi-stage,
stratified random cluster-sampling scheme. In the first
stage, three counties (Dawa, Zhangwu, and Liaoyang
County) were selected from the eastern, southern, and
northern regions of Liaoning province. In the second
stage, one town was randomly selected from each county
(a total of three towns). In the third stage, six to eight
rural villages near each town were randomly selected
(a total of 26 rural villages). Exclusion criteria for
individuals in the present study included pregnancy,
malignant tumor, or mental disorder. All the eligible per-
manent residents aged ≥35 years from each village were
invited to join the study (a total of 14 016 participants).
Of those, 11 956 participants responded and completed
the study: the response rate was 85.3%. All procedures
were performed in accordance with standard ethical
principles. Written consent was obtained from all par-
ticipants after they had been informed of the objectives,
benefits, medical procedures and the confidentiality of
personal information. For illiterate participants, we
obtained written informed consent from their proxies. In
this report, we used data obtained at baseline, and only
participants with a complete set of data for the variables
analyzed in the study were included, making a final
sample size of 11 345 (5253 men and 6092 women).
Data collection and measurements
Data were collected during a single clinic visit by trained
doctors and nurses using a standard questionnaire by
face-to-face interview. Before the survey was performed,
all eligible investigators were invited to attend training.
The training content included the purpose of this study,
how to administer the questionnaire, the standard me-
thods of measurement, the study procedures, and the
importance of standardization. After the training a strict
test was carried out, and only those who scored perfectly
on the test could become investigators. During data col-
lection, our inspectors received further instructions and
support. There was a central steering committee with a
subcommittee for quality control.
Data on demographic characteristics, lifestyle risk fac-
tors, dietary habits, family income, family history of car-
diovascular disease and medical history of hypertension
were obtained by interview with a standardized question-
naire. Educational level was divided into primary school
or below, middle school, and high school or above. Family
income was classified as ≤5000, 5000–20 000 and >20 000
CNY/year.
According to the American Heart Association pro-
tocol, the investigators performed blood pressure (BP)
measurement three times for each participant at 2-min
intervals after at least 5 min of rest, using a standardized
automatic electronic sphygmomanometer (HEM-907;
Omron), which had already been validated according to
the British Hypertension Society protocol [12]. The par-
ticipants were advised to avoid caffeinated beverages and
exercise for at least 30 min before the measurement.
During the measurement, the participants were seated
with the arm supported at the level of the heart. The
average of three BP measures was calculated and used in
all analyses.
Weight and height were measured to the nearest 0.1
kg and 0.1 cm respectively, with the participants in light-
weight clothing and without shoes. Waist circumference
(WC) was measured (to the nearest 0.1 cm) at the um-
bilicus using a non-elastic tape, with the participants
standing, at the end of normal expiration. BMI was cal-
culated as weight in kilograms divided by the square of
the height in meters.
Fasting blood samples were collected from all partici-
pants in the morning after at least 12 h of fasting. Blood
samples were obtained from an antecubital vein into
Vacutainer tubes containing EDTA. Fasting plasma glu-
cose (FPG), total cholesterol (TC), low-density lipoprotein
cholesterol (LDL-C), high-density lipoprotein cholesterol
(HDL-C), triglyceride (TG), serum creatinine (Scr) and
other routine blood biochemical indexes were analyzed en-
zymatically on an autoanalyzer. All laboratory equipment
was calibrated, and blinded duplicate samples were used.
Definitions
According to the JNC-8 report [13], hypertension is
defined as SBP ≥140 mmHg and/or DBP ≥90 mmHg
and/or the use of antihypertensive medications. Ac-
cording to the World Health Organization (WHO) cri-
teria, BMI was categorized into three groups: normal
(BMI <25 kg/m2), overweight (25 ≤ BMI <30 kg/m2)
and obesity (BMI ≥30 kg/m2) [14]. Abdominal obesity
was defined as WC ≥88 cm for females and WC ≥102 cm
for males [15]. Dyslipidemia was defined according to the
National Cholesterol Education Program-Third Adult
Treatment Panel (ATP III) criteria [16]. High TC was
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defined as TC ≥6.21 mmol/L (240 mg/dL). Low HDL-C
was defined as HDL-C < 1.03 mmol/L (40 mg/dL). High
LDL-C was defined as LDL-C ≥4.16 mmol/L (160 mg/dL).
High TG was defined as TG ≥2.26 mmol/L (200 mg/dL).
Dyslipidemia was defined as having at least one of the dis-
orders mentioned above. Diabetes mellitus (DM) and
anemia were both diagnosed according to the WHO cri-
teria: DM was defined as FPG ≥7 mmol/L (126 mg/dL)
and/or being on treatment for diabetes; anemia was de-
fined as a hemoglobin level <13.0 g/dL (<130 g/L) for men
and <12.0 g/dL (<120 g/L) for women [17, 18]. Hyperuri-
caemia was determined as uric acid >422 μmol/L for men
and >363μmol/L for women [19]. Drinking and smoking
status were divided into current drinkers/smokers and
nondrinkers/smokers. Physical activity included occu-
pational and leisure-time physical activity. A detailed
description of the methods has been presented before
[20]. Occupational and leisure-time physical activity
were merged and regrouped into three categories: (1)
low—participants who reported light levels of both occu-
pational and leisure-time physical activity; (2) moderate—
participants who reported moderate or high levels of
either occupational or leisure-time physical activity; and
(3) high—participants who reported a moderate or high
level of both occupational and leisure-time physical
activity.
The dietary pattern was assessed using recall of foods
eaten in the previous year. First, the participants were
questioned on their average consumption of several food
items per week. The reported consumption was quantified
approximately in terms of grams per week (vegetable con-
sumption: rarely = 3, <1000 g = 2, 1000–2000g = 1, ≥2000
g = 0; meat consumption, including red meat, fish, and
poultry: rarely = 0, <250 g = 1, 250–500 g = 2, ≥500 g = 3).
Subsequently, a special diet score (vegetable consump-
tion score plus meat consumption score) was calcu-
lated for each participant (range 0–6). Higher values of
the diet score indicate higher meat consumption and
lower vegetable consumption and greater adherence to
a Westernized diet, while lower values indicate ad-
herence to the Chinese diet. Similar methods for cal-
culating diet score could be found in the ATTICA
study [21].
Assessment of glomerular filtration rate
Fasting blood samples were collected as described under
“Data collection and measurement”. Serum creatinine
(Scr) was measured enzymatically on an autoanalyzer.
The GFR was estimated using an equation originating from
the CKD Epidemiology Collaboration (CKD-EPI) equation
[22], which is more appropriate than the Modification of
Diet in Renal Disease (MDRD) Study group equation
[23]. Decreased GFR was defined as estimated GFR
(eGFR) <60 ml/min/1.73 m2.
Statistical analysis
Descriptive statistics were calculated for all the variables,
including continuous variables (reported as mean values
and standard deviations) and categorical variables (re-
ported as numbers and percentages). Differences among
them were evaluated using Student’s t-test, ANOVA,
non-parametric tests or the χ2-test as appropriate. Mul-
tivariate logistic regression analyses were used to identify
independent factors and associated comorbidities of de-
creased eGFR, with odds ratios (ORs) and corresponding
95 % confidence intervals (CIs) calculated. All the statis-
tical analyses were performed using SPSS version 17.0
software, and P values <0.05 were considered to be
statistically significant.
Results
Baseline characteristics of study population
Table 1 presents baseline characteristics of the participants
according to the eGFR categories and sex. Men with de-
creased eGFR (eGFR <60ml/min per 1.73m2) had higher
age, mean WC, systolic and diastolic BP, PP, MAP, total
fasting glucose, LDL-C, glyceride and uric acid levels and
were current drinker/smoker at the baseline (all P < 0.05).
Those with low education level, low income, low physical
activity, low hemoglobin and HDL-C level had decreased
eGFR (all P < 0.05). In women, the results were similar to
those of men, but DBP and drinking status had no asso-
ciation with the eGFR in women.
The prevalence of decreased eGFR by quartiles of MAP in
men and women
Figure 1 shows that the prevalence of decreased eGFR
by quartiles of MAP was different in men and women.
For men, the prevalence of decreased eGFR increased as
the MAP increased. The prevalence of decreased eGFR
in men was lowest when 93.8 ≤MAP < 101.8 mmHg,
while for women, when 98.4 ≤MAP < 109.1 mmHg, the
prevalence of decreased eGFR was lower than in the
group with lower MAP.
The OR and 95%CI for the prevalence of decreased eGFR
as a function of quartiles of MAP
Figure 2 shows that after adjustment for age, that men
with a MAP of >112.2 mmHg versus ≤93.8 mmHg had
an OR for decreased eGFR of 2.367 (95 % CI: 1.248 to
4.488).After multivariable adjustment, men with a MAP
of >112.2 mmHg versus ≤93.8 mmHg had an OR for
decreased eGFR of 3.249 (95 % CI: 1.394 to 7.575). In
women, MAP was not associated with decreased eGFR.
Discussion
This is, to our knowledge, the first study to compare the
association of MAP with decreased eGFR in a large
group of participants. In this study, we demonstrated
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that MAP was associated with decreased eGFR in males.
However, this association is not linear, from the lowest
level of MAP to the highest level, but is significant only
when MAP is >112.2 mmHg. It is well known that BP is
characterized by its pulsatile and steady components.
The pulsatile component, estimated by PP, represents BP
variation and is affected by left ventricular ejection
fraction, large-artery stiffness, early pulse wave reduc-
tion, and pulse rate [24, 25]. The steady component,
estimated by MAP, is a function of left ventricular con-
tractility, pulse rate, and vascular resistance and elasti-
city, averaged over time [26]. Adequate MAP is required
to protect renal function, because below a certain MAP
threshold, when autoregulation is exceeded, RBF de-
creases and this leads to acute renal injury [27]. When
MAP does not exceed a certain level, there is no signifi-
cant effect on renal function. With increasing MAP, the
vascular resistance and elasticity increase, the arteries
Table 1 Characteristics of subjects with eGFR ≥ 60 or eGFR < 60 by different genders
Male Female
Characteristics eGFR≥ 60 eGFR < 60 P value eGFR≥ 60 eGFR < 60 P value
N 5165 88 5939 153
Age (year) 54.13 ± 10.64 68.86 ± 10.46 <0.001 52.97 ± 10.05 68.73 ± 8.96 <0.001
MeanWC 83.71 ± 9.70 87.03 ± 10.34 0.004 81.17 ± 9.69 84.07 ± 10.30 <0.001
BMI (kg/m2) 24.72 ± 3.54 25.34 ± 3.77 0.168 24.85 ± 3.75 24.79 ± 3.91 1
Average SBP (mmHg) 143.30 ± 22.41 161.31 ± 26.31 <0.001 139.68 ± 23.80 154.23 ± 26.29 <0.001
Average DBP (mmHg) 83.66 ± 11.73 89.04 ± 16.33 0.002 80.49 ± 11.41 82.51 ± 14.78 0.11
PP (mmHg) 59.63 ± 16.34 72.27 ± 21.71 <0.001 59.19 ± 17.81 71.72 ± 20.84 <0.001
MAP (mmHg) 103.54 ± 14.14 113.13 ± 17.43 <0.001 100.22 ± 14.32 106.42 ± 16.71 <0.001
Race group (han, %) 4891,94.7 85,96.6 0.43 5633,94.8 150,98 0.076
Education <0.001 <0.001
Primary school or below (n, %) 2139,41.4 55,62.5 3325,56 133,86.9
Middle school (n, %) 2433, 47.1 26,29.5 2146,36.1 18,11.8
High school or above (n, %) 593,11.5 7,8.0 468,7.9 2,1.3
Income (CNY/year) <0.001 <0.001
<=5000 (n, %) 669,13 28,31.8 668,11.2 39,25.5
5000-20000 (n, %) 2780,53.8 43,48.9 3293,55.4 77,50.3
>20000 (n, %) 1716,33.2 17,19.3 1978,33.3 37,24.2
Current drinking status (n, %) 2376,46.0 13,14.8 <0.001 173,2.9 3,2.0 0.804
Current smoking status (n, %) 2976,57.6 26,29.5 <0.001 961,16.2 44,28.8 <0.001
History of stroke (n, %) 458,8.9 29,33 <0.001 480,8.1 29,19.0 <0.001
History of heart disease (n, %) 530,10.3 28,31.8 <0.001 914,18.4 63,41.2 <0.001
Physical activity <0.001 <0.001
Mild (n, %) 1132,21.9 51,58.0 2092,35.2 99,64.7
Moderate (n, %) 3746,72.5 35,39.8 154,59.2 41,26.8
High (n, %) 287,5.6 2,2.3 332,5.6 13,8.5
Laboratory parameters
Fasting glucose (mmol/L) 5.94 ± 1.65 6.58 ± 2.58 0.013 5.85 ± 1.58 6.54 ± 2.26 <0.001
Total cholesterol (mmol/L) 5.16 ± 1.03 5.45 ± 1.47 0.109 5.28 ± 1.09 5.98 ± 1.70 <0.001
Triglyceride (mmol/L) 1.66 ± 1.67 1.86 ± 1.59 0.005 1.60 ± 1.32 2.24 ± 1.75 <0.001
LDL-C (mmol/L) 2.87 ± .079 3.12 ± 1.01 0.03 2.96 ± 0.83 3.33 ± 1.14 <0.001
HDL-C (mmol/L) 1.41 ± 0.42 1.21 ± 0.27 <0.001 1.41 ± 0.34 1.35 ± 0.41 0.002
Hemoglobin (g/L) 148.95 ± 17.96 138.89 ± 20.56 <0.001 130.22 ± 14.50 125.75 ± 16.14 <0.001
Uric acid 331.85 ± 81.25 447.51 ± 122.02 <0.001 252.94 ± 64.55 362.89 ± 94.43 <0.001
Data are expressed as the mean ± SD or as n (%)
BMI Body mass index, WC Waist circumference, CNY Chinese Yuan (1 CNY = 0.161 USD), SBP Systolic blood pressure, DBP Diastolic blood pressure, LDL-C Low-density
lipoprotein cholesterol, HDL-C High-density lipoprotein cholesterol
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become progressively more stiff, and finally eGFR is
decreased.
In our study, there were significant differences be-
tween men and women: in the latter, MAP was not asso-
ciated with decreased eGFR. The trend of the prevalence
of decreased eGFR as a function of quartiles of MAP
appeared as a U-shaped curve. Recent studies have indi-
cated that sex hormones play important roles in regulat-
ing the structure and/or function of the kidney, causing
sex differences in a variety of characteristics [28–30].
Sex hormones affect the structure of the renal tubules
and various aspects of renal functions in experimental
animals and humans. Most of today’s knowledge is based
on studies in rodents showing that sex-dependent phe-
nomena in kidneys take place at the level of mRNA and/or
protein expression of various transporters in the apical
and basolateral membranes of the cells in specific parts of
the nephron [31].
The limitation of this study should be considered in
the light of the results. The study was cross-sectional,
and therefore patients with decreased eGFR were identi-
fied retrospectively.
Conclusions
In conclusion, MAP was associated with decreased eGFR
in men, while in women MAP was not associated with
decreased eGFR. These findings provide some evidence
that a different adaptive response to renal regulation
may exist in males and females, and paves the way for
further studies aiming to identify the sex hormones
involved in this mechanism.
Fig. 1 The prevalence of decreased eGFR by quartiles of MAP in men and women
Fig. 2 The OR and 95 % CI for the prevalence of decreased eGFR as a function of quartiles of MAP. Multivariable analysis adjusted for age, BMI,
WC, mean SBP, mean DBP, mean PP, smoking status, drinking status, ethnic group, education, income, history of stroke, history of heart disease,
total cholesterol, triglyceride, LDL-C, HDL-C, fasting glucose, hemoglobin, and uric acid
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